REPORTS

Let’s Pullulate and Expand Your Business

Antihelminthics Market - Global Professional Analysis and Forecast to 2026

Jan 21, 2020  |  222 PAGES  |  REPORT CODE: CMM262696
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Antihelminthics market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.0% during the forecast period.

This report presents the market size and development trends by detailing the Antihelminthics market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Antihelminthics market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Antihelminthics industry and will help you to build a panoramic view of the industrial development.

Antihelminthics Market, By Type:

  • Benzimidazoles

  • Abamectin

  • Salicylanilides

  • Praziquantel

  • Other

Antihelminthics Market, By Application:

  • Schistosomiasis

  • Fasciolasis

  • Filariasis

  • Angiostrongylosis

  • Ascariasis

  • Giardiasis

  • Other

Some of the leading players are as follows:

  • Merck & Co.

  • Novartis

  • Astellas Pharma

  • Johnson & Johnson

  • GlaxoSmithKline

  • ALLERGAN

  • ZEISS International

  • Pfizer

  • Abbott

  • Sanofi

  • Sanofi

  • AstraZeneca

  • Bayer

  • Mentis Pharma

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Antihelminthics Market: Technology Type Analysis

  • 4.1 Antihelminthics Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Antihelminthics Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Benzimidazoles

    • 4.3.2 Abamectin

    • 4.3.3 Salicylanilides

    • 4.3.4 Praziquantel

    • 4.3.5 Other

5 Antihelminthics Market: Product Analysis

  • 5.1 Antihelminthics Product Market Share Analysis, 2018 & 2026

  • 5.2 Antihelminthics Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Antihelminthics Market: Application Analysis

  • 6.1 Antihelminthics Application Market Share Analysis, 2018 & 2026

  • 6.2 Antihelminthics Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Schistosomiasis

    • 6.3.2 Fasciolasis

    • 6.3.3 Filariasis

    • 6.3.4 Angiostrongylosis

    • 6.3.5 Ascariasis

    • 6.3.6 Giardiasis

    • 6.3.7 Other

7 Antihelminthics Market: Regional Analysis

  • 7.1 Antihelminthics Regional Market Share Analysis, 2018 & 2026

  • 7.2 Antihelminthics Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Merck & Co.

    • 9.1.1 Merck & Co. Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Novartis

    • 9.2.1 Novartis Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Astellas Pharma

    • 9.3.1 Astellas Pharma Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Johnson & Johnson

    • 9.4.1 Johnson & Johnson Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 GlaxoSmithKline

    • 9.5.1 GlaxoSmithKline Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 ALLERGAN

    • 9.6.1 ALLERGAN Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 ZEISS International

    • 9.7.1 ZEISS International Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Pfizer

    • 9.8.1 Pfizer Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Abbott

    • 9.9.1 Abbott Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Sanofi

    • 9.10.1 Sanofi Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Sanofi

    • 9.11.1 Sanofi Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 AstraZeneca

    • 9.12.1 AstraZeneca Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 Bayer

    • 9.13.1 Bayer Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

  • 9.14 Mentis Pharma

    • 9.14.1 Mentis Pharma Company overview

    • 9.14.2 Financial performance

    • 9.14.3 Product benchmarking

    • 9.14.4 Strategic initiatives

    • 9.14.5 SWOT analysis

 

The List of Tables and Figures (Totals 62 Figures and 153 Tables)

  • Figure Benzimidazoles Antihelminthics market, 2015 - 2026 (USD Million)

  • Figure Abamectin Antihelminthics market, 2015 - 2026 (USD Million)

  • Figure Salicylanilides Antihelminthics market, 2015 - 2026 (USD Million)

  • Figure Praziquantel Antihelminthics market, 2015 - 2026 (USD Million)

  • Figure Other Antihelminthics market, 2015 - 2026 (USD Million)

  • Figure Schistosomiasis market, 2015 - 2026 (USD Million)

  • Figure Fasciolasis market, 2015 - 2026 (USD Million)

  • Figure Filariasis market, 2015 - 2026 (USD Million)

  • Figure Angiostrongylosis market, 2015 - 2026 (USD Million)

  • Figure Ascariasis market, 2015 - 2026 (USD Million)

  • Figure Giardiasis market, 2015 - 2026 (USD Million)

  • Figure Other market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Antihelminthics market, by country, 2015 - 2026 (USD Million)

  • Table North America Antihelminthics market, by type, 2015 - 2026 (USD Million)

  • Table North America Antihelminthics market, by product, 2015 - 2026 (USD Million)

  • Table North America Antihelminthics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Antihelminthics market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Antihelminthics market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Antihelminthics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Antihelminthics market, by type, 2015 - 2026 (USD Million)

  • Table Canada Antihelminthics market, by product, 2015 - 2026 (USD Million)

  • Table Canada Antihelminthics market, by application, 2015 - 2026 (USD Million)

  • Table Europe Antihelminthics market, by country, 2015 - 2026 (USD Million)

  • Table Europe Antihelminthics market, by type, 2015 - 2026 (USD Million)

  • Table Europe Antihelminthics market, by product, 2015 - 2026 (USD Million)

  • Table Europe Antihelminthics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Antihelminthics market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Antihelminthics market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Antihelminthics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Antihelminthics market, by type, 2015 - 2026 (USD Million)

  • Table Germany Antihelminthics market, by product, 2015 - 2026 (USD Million)

  • Table Germany Antihelminthics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Antihelminthics market, by type, 2015 - 2026 (USD Million)

  • Table France Antihelminthics market, by product, 2015 - 2026 (USD Million)

  • Table France Antihelminthics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Antihelminthics market, by type, 2015 - 2026 (USD Million)

  • Table Italy Antihelminthics market, by product, 2015 - 2026 (USD Million)

  • Table Italy Antihelminthics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Antihelminthics market, by type, 2015 - 2026 (USD Million)

  • Table Spain Antihelminthics market, by product, 2015 - 2026 (USD Million)

  • Table Spain Antihelminthics market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Antihelminthics market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Antihelminthics market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Antihelminthics market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Antihelminthics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Antihelminthics market, by type, 2015 - 2026 (USD Million)

  • Table China Antihelminthics market, by product, 2015 - 2026 (USD Million)

  • Table China Antihelminthics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Antihelminthics market, by type, 2015 - 2026 (USD Million)

  • Table Japan Antihelminthics market, by product, 2015 - 2026 (USD Million)

  • Table Japan Antihelminthics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Antihelminthics market, by type, 2015 - 2026 (USD Million)

  • Table India Antihelminthics market, by product, 2015 - 2026 (USD Million)

  • Table India Antihelminthics market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Antihelminthics market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Antihelminthics market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Antihelminthics market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Antihelminthics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Antihelminthics market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Antihelminthics market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Antihelminthics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Antihelminthics market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Antihelminthics market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Antihelminthics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Antihelminthics market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Antihelminthics market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Antihelminthics market, by application, 2015 - 2026 (USD Million)

  • Table MEA Antihelminthics market, by country, 2015 - 2026 (USD Million)

  • Table MEA Antihelminthics market, by type, 2015 - 2026 (USD Million)

  • Table MEA Antihelminthics market, by product, 2015 - 2026 (USD Million)

  • Table MEA Antihelminthics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Antihelminthics market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Antihelminthics market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Antihelminthics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Antihelminthics market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Antihelminthics market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Antihelminthics market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Merck & Co. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Novartis Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Astellas Pharma Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Johnson & Johnson Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table GlaxoSmithKline Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table ALLERGAN Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table ZEISS International Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Pfizer Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Abbott Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sanofi Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sanofi Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table AstraZeneca Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Bayer Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Mentis Pharma Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top